- The US Commerce Department has defined specific specialty pharmaceutical categories eligible for zero Section 232 tariffs under Proclamation 11020.
- Nineteen jurisdictions, including the EU, Japan, and the UK, are identified as eligible for these tariff adjustments based on trade agreements.
- Companies can also apply for tariff exemption for products meeting an urgent US health need, with submissions processed individually and requiring a one-product-per-application approach.
Source EY
Latest Posts in "United States"
- North Carolina Taxes Entire Bundled Charge for Agency Services and Digital Property
- Missouri Updates Sales and Use Tax Rules for Third-Party Shipments
- United States Enacts Tariffs of Up to 500% on Russian Goods and 100% on Goods from Certain Russian Energy Buyers
- Illinois Targeted Advertising Tax Challenged Before 2027 Effective Date
- Ohio Supreme Court Remands Financial-Services Sales Tax Case for Clearer Analysis
